Results 151 to 160 of about 469,352 (221)

Safety, Immunogenicity of Co-Administered Vaccines, and Lot-to-Lot Consistency of a 14-Valent Pneumococcal Conjugate Vaccine (PNEUBEVAX 14^®) Administered at 6-10-14 Weeks in Healthy Infants: A Multicenter, Phase IV Trial. [PDF]

Vaccines (Basel)
Thuluva S, Gunneri S, Ningaiah S, Yerroju V, Mogulla RR, Thammireddy K, Dhar C, Desai S, Paliwal P, Loka C, Balne N, Kommanapalli S, Joshi C, Agarwal KS, Charde GP, Narang M, Narayan JP, Chakravarthy BS, Mahantshetti NS, Jog PP, Virupakshappa PM, Verma S, Pandey M, Thakkar PA.   +23 more
europepmc   +1 more source

Fractional Doses of Pneumococcal Conjugate Vaccine - A Noninferiority Trial. [PDF]

N Engl J Med
Gallagher KE, Lucinde R, Bottomley C, Kaniu M, Suaad B, Mutahi M, Mwalekwa L, Ragab S, Twi-Yeboah L, Berkley JA, Hamaluba M, Karani A, Shangala J, Otiende M, Gardiner E, Mugo D, Smith PG, Tabu C, Were F, Goldblatt D, Scott JAG.   +20 more
europepmc   +1 more source

Eighteen-Year Longitudinal Study of Uncomplicated and Complex Acute Otitis Media During the Pneumococcal Conjugate Vaccine Era, 2006-2023. [PDF]

J Infect Dis
Fuji N, Salamone FN, Kaur R, Bajorski P, Gonzalez E, Wang L, Ali M, Miller A, Grant LR, Arguedas A, Pichichero ME.   +10 more
europepmc   +1 more source

10-Year Effects of the 13-Valent Pneumococcal Conjugate Vaccine in Patients with Chronic Obstructive Pulmonary Disease and Stable Angina Pectoris. [PDF]

Vaccines (Basel)
Ignatova GL, Avdeev SN, Antonov VN, Blinova EV, Osikov MV.   +4 more
europepmc   +1 more source

Cost-effectiveness analysis of routine pediatric vaccination of 15-valent pneumococcal conjugate vaccine in South Korea. [PDF]

Hum Vaccin Immunother
Choe YJ, Jeon Y, Park J, Kim H, Yang G, Mohanty S, Floros L, Huang M, Chhabra N, Kumari S, Singh J, Sukarom I.   +11 more
europepmc   +1 more source

Serotype distribution and antimicrobial susceptibility patterns of Streptococcus pneumoniae isolates in the post-pneumococcal conjugate vaccine era in Nigeria: a hospital-based cross-sectional study. [PDF]

BMC Infect Dis
Joy N, Ebere O, Tochukwu N, Onochie-Igbinedion I, Harrison A, Charles E, Ikegbunam M.   +6 more
europepmc   +1 more source

Immunogenicity and Safety of the Higher-Valent Pneumococcal Conjugate Vaccine vs the 13-Valent Pneumococcal Conjugate Vaccine in Older Adults: A Systematic Review and Meta-analysis of Randomized Controlled Trials. [PDF]

Open Forum Infect Dis
Ngamprasertchai T, Ruenroengbun N, Kajeekul R.   +2 more
europepmc   +1 more source

Safety and Immunogenicity of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and Infants. [PDF]

Pediatr Infect Dis J
Pichon S, Ullery GM, Cousin L, Sadarangani M, Ryu JH, Monfredo C, Mari K, Pandey A, Personnic S, Pouzet C, Manson C, Silhadi W, Minutello AM.   +12 more
europepmc   +1 more source

Clinical and evidence-based considerations for choosing a pneumococcal conjugate vaccine in India: A narrative review. [PDF]

Hum Vaccin Immunother
Yewale V, Chatterjee P, Marathe SM, Taur S, Sathyanarayanan S.   +4 more
europepmc   +1 more source